The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was named:
"Cystine-knot cytokines
".
FunFam 3: Bone morphogenetic protein 5
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 14 GO terms relating to "molecular function"
			The search results have been sorted with the annotations that are found most frequently at the top of the
			list. The results can be filtered by typing text into the search box at the top of the table.
			
			
	| GO Term | Annotations | Evidence | 
|---|---|---|
| 
				Protein binding GO:0005515
				 Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). 
			 | 
			27 | 			
			A8K571 (/IPI)
						
			A8K571 (/IPI)
						
			A8K571 (/IPI)
						
			A8K571 (/IPI)
						
			A8K571 (/IPI)
						
			A8K571 (/IPI)
						
			A8K571 (/IPI)
						
			A8K571 (/IPI)
						
			A8K571 (/IPI)
						
			A8K571 (/IPI)
							 (17 more) 			 | 
		
| 
				BMP receptor binding GO:0070700
				 Interacting selectively and non-covalently with a BMP receptor. 
			 | 
			11 | 			
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
							 (1 more) 			 | 
		
| 
				BMP receptor binding GO:0070700
				 Interacting selectively and non-covalently with a BMP receptor. 
			 | 
			5 | P20722 (/ISO) P23359 (/ISO) P23359 (/ISO) P49003 (/ISO) P49003 (/ISO) | 
| 
				Protein heterodimerization activity GO:0046982
				 Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer. 
			 | 
			3 | P27091 (/IPI) P27091 (/IPI) Q9PTF9 (/IPI) | 
| 
				Cytokine activity GO:0005125
				 Functions to control the survival, growth, differentiation and effector function of tissues and cells. 
			 | 
			2 | P23359 (/TAS) P23359 (/TAS) | 
| 
				Transforming growth factor beta receptor binding GO:0005160
				 Interacting selectively and non-covalently with the transforming growth factor beta receptor. 
			 | 
			2 | P27091 (/ISS) P27091 (/ISS) | 
| 
				Heparin binding GO:0008201
				 Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. 
			 | 
			2 | G3V6W8 (/IDA) G3V6W8 (/IDA) | 
| 
				Heparin binding GO:0008201
				 Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Receptor ligand activity GO:0048018
				 The activity of a gene product that interacts with a receptor to effect a change in the activity of the receptor. Ligands may be produced by the same, or different, cell that expresses the receptor. Ligands may diffuse extracellularly from their point of origin to the receiving cell, or remain attached to an adjacent cell surface (e.g. Notch ligands). 
			 | 
			2 | P27091 (/IDA) P27091 (/IDA) | 
| 
				Growth factor activity GO:0008083
				 The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. 
			 | 
			1 | Q04906 (/IDA) | 
| 
				Growth factor activity GO:0008083
				 The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. 
			 | 
			1 | P20722 (/ISO) | 
| 
				Protein homodimerization activity GO:0042803
				 Interacting selectively and non-covalently with an identical protein to form a homodimer. 
			 | 
			1 | Q9PTF9 (/IDA) | 
| 
				Protein heterodimerization activity GO:0046982
				 Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer. 
			 | 
			1 | P22004 (/IDA) | 
| 
				Protein heterodimerization activity GO:0046982
				 Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer. 
			 | 
			1 | P20722 (/ISO) | 
There are 255 GO terms relating to "biological process"
			The search results have been sorted with the annotations that are found most frequently at the top of the
			list. The results can be filtered by typing text into the search box at the top of the table.
			
			
	| GO Term | Annotations | Evidence | 
|---|---|---|
| 
				Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
				 Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. 
			 | 
			22 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (12 more) 			 | 
		
| 
				Endocardial cushion formation GO:0003272
				 The developmental process pertaining to the initial formation of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves. 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				Pericardium morphogenesis GO:0003344
				 The process in which the anatomical structure of the pericardium is generated and organized. 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				Neural fold elevation formation GO:0021502
				 The process in which the lateral borders of the neural plate begin to migrate upwards to form the neural folds, caused by the proliferation of the underlying mesoderm. 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				Hindbrain development GO:0030902
				 The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium). 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				Cardiac muscle tissue development GO:0048738
				 The process whose specific outcome is the progression of cardiac muscle over time, from its formation to the mature structure. 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				Pharyngeal system development GO:0060037
				 The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear. 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				Cardiac septum morphogenesis GO:0060411
				 The process in which the anatomical structure of a cardiac septum is generated and organized. A cardiac septum is a partition that separates parts of the heart. 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				Chorio-allantoic fusion GO:0060710
				 The cell-cell adhesion process in which the cells of the chorion fuse to the cells of the allantois. 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				Heart trabecula morphogenesis GO:0061384
				 The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue. 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				Positive regulation of dendrite development GO:1900006
				 Any process that activates or increases the frequency, rate or extent of dendrite development. 
			 | 
			21 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (11 more) 			 | 
		
| 
				Allantois development GO:1905069
				 The process whose specific outcome is the progression of an allantois over time, from its formation to the mature structure. 
			 | 
			21 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (11 more) 			 | 
		
| 
				BMP signaling pathway GO:0030509
				 A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. 
			 | 
			17 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (7 more) 			 | 
		
| 
				BMP signaling pathway GO:0030509
				 A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. 
			 | 
			16 | 			
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
							 (6 more) 			 | 
		
| 
				Skeletal system development GO:0001501
				 The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). 
			 | 
			12 | 			
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
							 (2 more) 			 | 
		
| 
				Ureteric bud development GO:0001657
				 The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure. 
			 | 
			12 | 			
			O88684 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (2 more) 			 | 
		
| 
				Positive regulation of bone mineralization GO:0030501
				 Any process that activates or increases the frequency, rate or extent of bone mineralization. 
			 | 
			12 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (2 more) 			 | 
		
| 
				Positive regulation of osteoblast differentiation GO:0045669
				 Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. 
			 | 
			12 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (2 more) 			 | 
		
| 
				SMAD protein signal transduction GO:0060395
				 The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell. 
			 | 
			12 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (2 more) 			 | 
		
| 
				Mesenchyme development GO:0060485
				 The process whose specific outcome is the progression of a mesenchymal tissue over time, from its formation to the mature structure. A mesenchymal tissue is made up of loosely packed stellate cells. 
			 | 
			12 | 			
			O88684 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (2 more) 			 | 
		
| 
				Cellular response to BMP stimulus GO:0071773
				 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus. 
			 | 
			12 | 			
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
							 (2 more) 			 | 
		
| 
				Metanephros development GO:0001656
				 The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine. 
			 | 
			11 | 			
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
							 (1 more) 			 | 
		
| 
				Mesonephros development GO:0001823
				 The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney. 
			 | 
			11 | 			
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
						
			P18075 (/IEP)
							 (1 more) 			 | 
		
| 
				Epithelial to mesenchymal transition GO:0001837
				 A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. 
			 | 
			11 | 			
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
							 (1 more) 			 | 
		
| 
				Type B pancreatic cell development GO:0003323
				 The process whose specific outcome is the progression of a type B pancreatic cell over time, from its formation to the mature structure. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin. 
			 | 
			11 | 			
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
							 (1 more) 			 | 
		
| 
				Positive regulation of gene expression GO:0010628
				 Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Negative regulation of striated muscle cell apoptotic process GO:0010664
				 Any process that decreases the rate or extent of striated muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a striated muscle cell and result in its death. 
			 | 
			11 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (1 more) 			 | 
		
| 
				Positive regulation of peptidyl-threonine phosphorylation GO:0010800
				 Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
				 Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. 
			 | 
			11 | 			
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
							 (1 more) 			 | 
		
| 
				Dendrite development GO:0016358
				 The process whose specific outcome is the progression of the dendrite over time, from its formation to the mature structure. 
			 | 
			11 | 			
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
							 (1 more) 			 | 
		
| 
				Negative regulation of NF-kappaB transcription factor activity GO:0032088
				 Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB. 
			 | 
			11 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (1 more) 			 | 
		
| 
				Positive regulation of heterotypic cell-cell adhesion GO:0034116
				 Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Protein localization to nucleus GO:0034504
				 A process in which a protein transports or maintains the localization of another protein to the nucleus. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Negative regulation of phosphorylation GO:0042326
				 Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Steroid hormone mediated signaling pathway GO:0043401
				 A series of molecular signals mediated by a steroid hormone binding to a receptor. 
			 | 
			11 | 			
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
						
			P18075 (/IMP)
							 (1 more) 			 | 
		
| 
				Negative regulation of MAP kinase activity GO:0043407
				 Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Negative regulation of neuron differentiation GO:0045665
				 Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Negative regulation of cell cycle GO:0045786
				 Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Negative regulation of mitotic nuclear division GO:0045839
				 Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Negative regulation of transcription, DNA-templated GO:0045892
				 Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Positive regulation of transcription, DNA-templated GO:0045893
				 Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Positive regulation of transcription by RNA polymerase II GO:0045944
				 Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. 
			 | 
			11 | 			
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
							 (1 more) 			 | 
		
| 
				Mesenchymal cell differentiation GO:0048762
				 The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Neuron projection morphogenesis GO:0048812
				 The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Positive regulation of epithelial cell proliferation GO:0050679
				 Any process that activates or increases the rate or extent of epithelial cell proliferation. 
			 | 
			11 | 			
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
						
			P22003 (/IDA)
							 (1 more) 			 | 
		
| 
				Regulation of pathway-restricted SMAD protein phosphorylation GO:0060393
				 Any process that modulates the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Negative regulation of cell death GO:0060548
				 Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Monocyte aggregation GO:0070487
				 The adhesion of one monocyte to one or more other monocytes via adhesion molecules. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Cellular response to hypoxia GO:0071456
				 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level. 
			 | 
			11 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (1 more) 			 | 
		
| 
				Negative regulation of glomerular mesangial cell proliferation GO:0072125
				 Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Positive regulation of hyaluranon cable assembly GO:1900106
				 Any process that activates or increases the frequency, rate or extent of hyaluranon cable assembly. 
			 | 
			11 | 			
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (1 more) 			 | 
		
| 
				Negative regulation of NIK/NF-kappaB signaling GO:1901223
				 Any process that stops, prevents or reduces the frequency, rate or extent of NIK/NF-kappaB signaling. 
			 | 
			11 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (1 more) 			 | 
		
| 
				Regulation of removal of superoxide radicals GO:2000121
				 Any process that modulates the frequency, rate or extent of removal of superoxide radicals. 
			 | 
			11 | 			
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
						
			P18075 (/ISS)
							 (1 more) 			 | 
		
| 
				Skeletal system development GO:0001501
				 The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). 
			 | 
			10 | P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) | 
| 
				Positive regulation of cell population proliferation GO:0008284
				 Any process that activates or increases the rate or extent of cell proliferation. 
			 | 
			10 | P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) | 
| 
				Negative regulation of cell population proliferation GO:0008285
				 Any process that stops, prevents or reduces the rate or extent of cell proliferation. 
			 | 
			10 | P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) | 
| 
				Negative regulation of epithelial to mesenchymal transition GO:0010719
				 Any process that decreases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. 
			 | 
			10 | P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) | 
| 
				Negative regulation of steroid biosynthetic process GO:0010894
				 Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus. 
			 | 
			10 | P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) | 
| 
				Negative regulation of aldosterone biosynthetic process GO:0032348
				 Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of aldosterone. 
			 | 
			10 | P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) | 
| 
				Negative regulation of insulin-like growth factor receptor signaling pathway GO:0043569
				 Any process that stops, prevents, or reduces the frequency, rate or extent of insulin-like growth factor receptor signaling. 
			 | 
			10 | P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) | 
| 
				Negative regulation of mononuclear cell migration GO:0071676
				 Any process that decreases the rate, frequency or extent of mononuclear cell migration. Mononuclear cell migration is the movement of a mononuclear cell within or between different tissues and organs of the body. 
			 | 
			10 | P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) | 
| 
				Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042
				 Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors. 
			 | 
			10 | P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) P22003 (/NAS) | 
| 
				Negative regulation of cortisol biosynthetic process GO:2000065
				 Any process that stops, prevents, or reduces the frequency, rate or extent of cortisol biosynthetic process. 
			 | 
			10 | P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) P22003 (/IDA) | 
| 
				Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
				 Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. 
			 | 
			5 | P20722 (/ISO) P23359 (/ISO) P23359 (/ISO) P49003 (/ISO) P49003 (/ISO) | 
| 
				Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
				 Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. 
			 | 
			5 | P20722 (/ISS) P22004 (/ISS) P23359 (/ISS) P23359 (/ISS) Q04906 (/ISS) | 
| 
				SMAD protein signal transduction GO:0060395
				 The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell. 
			 | 
			5 | P20722 (/ISS) P22004 (/ISS) P23359 (/ISS) P23359 (/ISS) Q04906 (/ISS) | 
| 
				Endocardial cushion formation GO:0003272
				 The developmental process pertaining to the initial formation of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves. 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Pericardium morphogenesis GO:0003344
				 The process in which the anatomical structure of the pericardium is generated and organized. 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Pattern specification process GO:0007389
				 Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate. 
			 | 
			4 | P23359 (/IMP) P23359 (/IMP) P49003 (/IMP) P49003 (/IMP) | 
| 
				Neural fold elevation formation GO:0021502
				 The process in which the lateral borders of the neural plate begin to migrate upwards to form the neural folds, caused by the proliferation of the underlying mesoderm. 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Hindbrain development GO:0030902
				 The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium). 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Cardiac muscle tissue development GO:0048738
				 The process whose specific outcome is the progression of cardiac muscle over time, from its formation to the mature structure. 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Pharyngeal system development GO:0060037
				 The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear. 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Cardiac septum morphogenesis GO:0060411
				 The process in which the anatomical structure of a cardiac septum is generated and organized. A cardiac septum is a partition that separates parts of the heart. 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Chorio-allantoic fusion GO:0060710
				 The cell-cell adhesion process in which the cells of the chorion fuse to the cells of the allantois. 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Heart trabecula morphogenesis GO:0061384
				 The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue. 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Positive regulation of dendrite development GO:1900006
				 Any process that activates or increases the frequency, rate or extent of dendrite development. 
			 | 
			4 | P23359 (/ISO) P23359 (/ISO) P49003 (/ISO) P49003 (/ISO) | 
| 
				Allantois development GO:1905069
				 The process whose specific outcome is the progression of an allantois over time, from its formation to the mature structure. 
			 | 
			4 | P23359 (/IGI) P23359 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Type B pancreatic cell development GO:0003323
				 The process whose specific outcome is the progression of a type B pancreatic cell over time, from its formation to the mature structure. A type B pancreatic cell is a cell located towards center of the islets of Langerhans that secretes insulin. 
			 | 
			3 | P20722 (/ISO) P49003 (/ISO) P49003 (/ISO) | 
| 
				Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
				 Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. 
			 | 
			3 | A0A0R4ILD5 (/IMP) P20722 (/IMP) Q7T288 (/IMP) | 
| 
				Positive regulation of bone mineralization GO:0030501
				 Any process that activates or increases the frequency, rate or extent of bone mineralization. 
			 | 
			3 | P20722 (/ISO) P23359 (/ISO) P23359 (/ISO) | 
| 
				BMP signaling pathway GO:0030509
				 A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. 
			 | 
			3 | P20722 (/ISO) P23359 (/ISO) P23359 (/ISO) | 
| 
				Male genitalia development GO:0030539
				 The process whose specific outcome is the progression of the male genitalia over time, from its formation to the mature structure. 
			 | 
			3 | P20722 (/IGI) P49003 (/IGI) P49003 (/IGI) | 
| 
				Positive regulation of neuron differentiation GO:0045666
				 Any process that activates or increases the frequency, rate or extent of neuron differentiation. 
			 | 
			3 | P20722 (/IDA) P23359 (/IDA) P23359 (/IDA) | 
| 
				Positive regulation of osteoblast differentiation GO:0045669
				 Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. 
			 | 
			3 | P20722 (/ISO) P23359 (/ISO) P23359 (/ISO) | 
| 
				Positive regulation of transcription by RNA polymerase II GO:0045944
				 Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. 
			 | 
			3 | P22004 (/IGI) P23359 (/IGI) P23359 (/IGI) | 
| 
				Positive regulation of transcription by RNA polymerase II GO:0045944
				 Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. 
			 | 
			3 | P20722 (/ISO) P49003 (/ISO) P49003 (/ISO) | 
| 
				Positive regulation of epithelial cell proliferation GO:0050679
				 Any process that activates or increases the rate or extent of epithelial cell proliferation. 
			 | 
			3 | P20722 (/ISO) P49003 (/ISO) P49003 (/ISO) | 
| 
				SMAD protein signal transduction GO:0060395
				 The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell. 
			 | 
			3 | P20722 (/ISO) P23359 (/ISO) P23359 (/ISO) | 
| 
				Cellular response to BMP stimulus GO:0071773
				 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus. 
			 | 
			3 | P20722 (/ISO) P23359 (/ISO) P23359 (/ISO) | 
| 
				Positive regulation of progesterone secretion GO:2000872
				 Any process that activates or increases the frequency, rate or extent of progesterone secretion. 
			 | 
			3 | F1NUT2 (/TAS) F1P4H2 (/TAS) Q9I8T6 (/TAS) | 
| 
				Skeletal system development GO:0001501
				 The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton). 
			 | 
			2 | P49003 (/IMP) P49003 (/IMP) | 
| 
				Eye development GO:0001654
				 The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Ureteric bud development GO:0001657
				 The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Mesoderm formation GO:0001707
				 The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Kidney development GO:0001822
				 The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Neuromuscular synaptic transmission GO:0007274
				 The process of synaptic transmission from a neuron to a muscle, across a synapse. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Dorsal closure GO:0007391
				 The process during Drosophila embryogenesis whereby the ectodermal cells of the lateral epithelium stretch in a coordinated fashion to internalize the amnioserosa cells and close the embryo dorsally. 
			 | 
			2 | P27091 (/TAS) P27091 (/TAS) | 
| 
				Axon guidance GO:0007411
				 The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues. 
			 | 
			2 | P23359 (/IDA) P23359 (/IDA) | 
| 
				Ventral cord development GO:0007419
				 The process whose specific outcome is the progression of the ventral cord over time, from its formation to the mature structure. The ventral cord is one of the distinguishing traits of the central nervous system of all arthropods (such as insects, crustaceans and arachnids) as well as many other invertebrates, such as the annelid worms. 
			 | 
			2 | P27091 (/HMP) P27091 (/HMP) | 
| 
				Salivary gland morphogenesis GO:0007435
				 The process in which the anatomical structures of the salivary gland are generated and organized. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Imaginal disc-derived wing vein specification GO:0007474
				 The regionalization process in which the area of a imaginal disc-derived wing that will form a wing vein is specified. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Larval fat body development GO:0007504
				 The process whose specific outcome is the progression of the larval fat body over time, from its formation to the mature structure. The larval fat body consists of a bilaterally symmetrical monolayer of cells lying between the gut and the muscles of the body wall. As in other tissues of the larva, the cells of the fat body complete their divisions in the embryo and increase in size and ploidy during larval life. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Neuromuscular junction development GO:0007528
				 A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a neuromuscular junction. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Positive regulation of cell population proliferation GO:0008284
				 Any process that activates or increases the rate or extent of cell proliferation. 
			 | 
			2 | P49003 (/ISO) P49003 (/ISO) | 
| 
				Negative regulation of cell population proliferation GO:0008285
				 Any process that stops, prevents or reduces the rate or extent of cell proliferation. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Negative regulation of cell population proliferation GO:0008285
				 Any process that stops, prevents or reduces the rate or extent of cell proliferation. 
			 | 
			2 | P49003 (/ISO) P49003 (/ISO) | 
| 
				Imaginal disc-derived wing vein morphogenesis GO:0008586
				 The process in which anatomical structures of the veins on an imaginal disc-derived wing are generated and organized. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Embryonic pattern specification GO:0009880
				 The process that results in the patterns of cell differentiation that will arise in an embryo. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Animal organ morphogenesis GO:0009887
				 Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Positive regulation of gene expression GO:0010628
				 Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Positive regulation of epithelial to mesenchymal transition GO:0010718
				 Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Positive regulation of peptidyl-threonine phosphorylation GO:0010800
				 Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of steroid biosynthetic process GO:0010894
				 Any process that decreases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus. 
			 | 
			2 | P49003 (/ISO) P49003 (/ISO) | 
| 
				Positive regulation of cell death GO:0010942
				 Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Neural crest cell development GO:0014032
				 The process aimed at the progression of a neural crest cell over time, from initial commitment of the cell to its specific fate, to the fully functional differentiated cell. 
			 | 
			2 | A0A0R4ILD5 (/IMP) Q7T288 (/IMP) | 
| 
				Embryonic limb morphogenesis GO:0030326
				 The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Embryonic limb morphogenesis GO:0030326
				 The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				BMP signaling pathway GO:0030509
				 A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. 
			 | 
			2 | P27091 (/IGI) P27091 (/IGI) | 
| 
				BMP signaling pathway GO:0030509
				 A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. 
			 | 
			2 | G3V6W8 (/TAS) G3V6W8 (/TAS) | 
| 
				Ovarian follicle cell development GO:0030707
				 The process that occurs during oogenesis involving the ovarian follicle cells, somatic cells which surround the germ cells of an ovary. An example of this is found in Drosophila melanogaster. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Epithelial cell differentiation GO:0030855
				 The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Negative regulation of aldosterone biosynthetic process GO:0032348
				 Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of aldosterone. 
			 | 
			2 | P49003 (/ISO) P49003 (/ISO) | 
| 
				Response to estradiol GO:0032355
				 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. 
			 | 
			2 | G3V6W8 (/IEP) G3V6W8 (/IEP) | 
| 
				Response to vitamin D GO:0033280
				 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus. 
			 | 
			2 | G3V6W8 (/IEP) G3V6W8 (/IEP) | 
| 
				Positive regulation of heterotypic cell-cell adhesion GO:0034116
				 Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Protein localization to nucleus GO:0034504
				 A process in which a protein transports or maintains the localization of another protein to the nucleus. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Protein localization to nucleus GO:0034504
				 A process in which a protein transports or maintains the localization of another protein to the nucleus. 
			 | 
			2 | P23359 (/ISS) P23359 (/ISS) | 
| 
				Wing disc pattern formation GO:0035222
				 The process giving rise to the pattern of cell differentiation in the wing imaginal disc. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Tube morphogenesis GO:0035239
				 The process in which the anatomical structures of a tube are generated and organized. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system. 
			 | 
			2 | P23359 (/IDA) P23359 (/IDA) | 
| 
				Female germ-line stem cell population maintenance GO:0036099
				 The process by which an organism or tissue maintains a population of female germ-line stem cells. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Regulation of phosphorylation GO:0042325
				 Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule. 
			 | 
			2 | G3V6W8 (/IMP) G3V6W8 (/IMP) | 
| 
				Regulation of phosphorylation GO:0042325
				 Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of phosphorylation GO:0042326
				 Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of phosphorylation GO:0042326
				 Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule. 
			 | 
			2 | P23359 (/ISS) P23359 (/ISS) | 
| 
				Odontogenesis of dentin-containing tooth GO:0042475
				 The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel. 
			 | 
			2 | P23359 (/IDA) P23359 (/IDA) | 
| 
				Positive regulation of apoptotic process GO:0043065
				 Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Steroid hormone mediated signaling pathway GO:0043401
				 A series of molecular signals mediated by a steroid hormone binding to a receptor. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of MAP kinase activity GO:0043407
				 Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of MAP kinase activity GO:0043407
				 Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity. 
			 | 
			2 | P23359 (/ISS) P23359 (/ISS) | 
| 
				Response to peptide hormone GO:0043434
				 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals. 
			 | 
			2 | G3V6W8 (/IEP) G3V6W8 (/IEP) | 
| 
				Negative regulation of insulin-like growth factor receptor signaling pathway GO:0043569
				 Any process that stops, prevents, or reduces the frequency, rate or extent of insulin-like growth factor receptor signaling. 
			 | 
			2 | P49003 (/ISO) P49003 (/ISO) | 
| 
				Ear development GO:0043583
				 The process whose specific outcome is the progression of the ear over time, from its formation to the mature structure. The ear is the sense organ in vertebrates that is specialized for the detection of sound, and the maintenance of balance. Includes the outer ear and middle ear, which collect and transmit sound waves; and the inner ear, which contains the organs of balance and (except in fish) hearing. Also includes the pinna, the visible part of the outer ear, present in some mammals. 
			 | 
			2 | P49003 (/IMP) P49003 (/IMP) | 
| 
				R8 cell fate specification GO:0045464
				 The process in which a cell becomes capable of differentiating autonomously into an R8 cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Positive regulation of cell differentiation GO:0045597
				 Any process that activates or increases the frequency, rate or extent of cell differentiation. 
			 | 
			2 | P23359 (/IDA) P23359 (/IDA) | 
| 
				Negative regulation of neuron differentiation GO:0045665
				 Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Negative regulation of neuron differentiation GO:0045665
				 Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of Notch signaling pathway GO:0045746
				 Any process that stops, prevents, or reduces the frequency, rate or extent of the Notch signaling pathway. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Negative regulation of cell cycle GO:0045786
				 Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of mitotic nuclear division GO:0045839
				 Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of mitotic nuclear division GO:0045839
				 Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother. 
			 | 
			2 | P23359 (/ISS) P23359 (/ISS) | 
| 
				Positive regulation of synaptic growth at neuromuscular junction GO:0045887
				 Any process that activates or increases the frequency, rate or extent of synaptic growth at neuromuscular junction. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Negative regulation of transcription, DNA-templated GO:0045892
				 Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of transcription, DNA-templated GO:0045892
				 Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. 
			 | 
			2 | P23359 (/ISS) P23359 (/ISS) | 
| 
				Positive regulation of transcription, DNA-templated GO:0045893
				 Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Regulation of neurotransmitter secretion GO:0046928
				 Any process that modulates the frequency, rate or extent of the regulated release of a neurotransmitter from a cell. 
			 | 
			2 | P27091 (/IDA) P27091 (/IDA) | 
| 
				Cell development GO:0048468
				 The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate. 
			 | 
			2 | P23359 (/IDA) P23359 (/IDA) | 
| 
				Embryonic digestive tract morphogenesis GO:0048557
				 The process in which the anatomical structures of the digestive tract are generated and organized during embryonic development. The digestive tract is the anatomical structure through which food passes and is processed. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Camera-type eye morphogenesis GO:0048593
				 The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Embryonic camera-type eye morphogenesis GO:0048596
				 The process in which the anatomical structures of the eye are generated and organized during embryonic development. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Positive regulation of muscle organ development GO:0048636
				 Any process that activates, maintains or increases the rate of muscle development. 
			 | 
			2 | P27091 (/IGI) P27091 (/IGI) | 
| 
				Anatomical structure formation involved in morphogenesis GO:0048646
				 The developmental process pertaining to the initial formation of an anatomical structure from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Branching morphogenesis of an epithelial tube GO:0048754
				 The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder. 
			 | 
			2 | P23359 (/IDA) P23359 (/IDA) | 
| 
				Mesenchymal cell differentiation GO:0048762
				 The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Mesenchymal cell differentiation GO:0048762
				 The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types. 
			 | 
			2 | P23359 (/ISS) P23359 (/ISS) | 
| 
				Neuron projection morphogenesis GO:0048812
				 The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Neuron projection morphogenesis GO:0048812
				 The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of neurogenesis GO:0050768
				 Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system. 
			 | 
			2 | P23359 (/IDA) P23359 (/IDA) | 
| 
				Positive regulation of synaptic transmission GO:0050806
				 Any process that activates or increases the frequency, rate or extent of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. 
			 | 
			2 | P27091 (/IMP) P27091 (/IMP) | 
| 
				Embryonic skeletal joint morphogenesis GO:0060272
				 The process in which the anatomical structures of skeletal joints are generated and organized during the embryonic phase. A skeletal joint is the connecting structure between the bones of the skeleton. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Embryonic skeletal joint morphogenesis GO:0060272
				 The process in which the anatomical structures of skeletal joints are generated and organized during the embryonic phase. A skeletal joint is the connecting structure between the bones of the skeleton. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Regulation of pathway-restricted SMAD protein phosphorylation GO:0060393
				 Any process that modulates the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Branching involved in salivary gland morphogenesis GO:0060445
				 The process in which the branching structure of the salivary gland is generated and organized. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Mesenchyme development GO:0060485
				 The process whose specific outcome is the progression of a mesenchymal tissue over time, from its formation to the mature structure. A mesenchymal tissue is made up of loosely packed stellate cells. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Negative regulation of cell death GO:0060548
				 Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of prostatic bud formation GO:0060686
				 Any process that decreases the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth. 
			 | 
			2 | P23359 (/IDA) P23359 (/IDA) | 
| 
				Regulation of branching involved in prostate gland morphogenesis GO:0060687
				 Any process that modulates the rate, frequency, or extent of prostate gland branching, the process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Positive regulation of ERK1 and ERK2 cascade GO:0070374
				 Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. 
			 | 
			2 | A0A0R4ILD5 (/IMP) Q7T288 (/IMP) | 
| 
				Monocyte aggregation GO:0070487
				 The adhesion of one monocyte to one or more other monocytes via adhesion molecules. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis GO:0072040
				 Any process that reduces the occurrence or rate of mesenchymal stem cell death by apoptotic process that contributes to the shaping of the nephron. 
			 | 
			2 | P23359 (/IMP) P23359 (/IMP) | 
| 
				Negative regulation of glomerular mesangial cell proliferation GO:0072125
				 Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Negative regulation of glomerular mesangial cell proliferation GO:0072125
				 Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation. 
			 | 
			2 | P23359 (/ISS) P23359 (/ISS) | 
| 
				Metanephric mesenchyme morphogenesis GO:0072133
				 The process in which the anatomical structures of a metanephric mesenchymal tissue are generated and organized. Metanephric mesenchyme is the tissue made up of loosely connected mesenchymal cells in the metanephros. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Nephrogenic mesenchyme morphogenesis GO:0072134
				 The process in which the anatomical structures of a nephrogenic mesenchymal tissue are generated and organized. Nephrogenic mesenchyme is the tissue made up of loosely connected mesenchymal cells in the nephron. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Metanephric mesenchymal cell proliferation involved in metanephros development GO:0072136
				 The multiplication or reproduction of cells, resulting in the expansion of a metanephric mesenchymal cell population. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Anterior head development GO:0097065
				 The process whose specific outcome is the progression of the anterior part of the head over time, from its formation to the mature structure. 
			 | 
			2 | P49003 (/IMP) P49003 (/IMP) | 
| 
				Positive regulation of hyaluranon cable assembly GO:1900106
				 Any process that activates or increases the frequency, rate or extent of hyaluranon cable assembly. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis GO:1905312
				 Any process that activates or increases the frequency, rate or extent of cardiac neural crest cell migration involved in outflow tract morphogenesis. 
			 | 
			2 | P23359 (/IGI) P23359 (/IGI) | 
| 
				Negative regulation of cortisol biosynthetic process GO:2000065
				 Any process that stops, prevents, or reduces the frequency, rate or extent of cortisol biosynthetic process. 
			 | 
			2 | P49003 (/ISO) P49003 (/ISO) | 
| 
				Negative regulation of transcription by RNA polymerase II GO:0000122
				 Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. 
			 | 
			1 | P20722 (/IMP) | 
| 
				Negative regulation of transcription by RNA polymerase II GO:0000122
				 Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. 
			 | 
			1 | P22004 (/ISS) | 
| 
				Ossification GO:0001503
				 The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance. 
			 | 
			1 | Q04906 (/IDA) | 
| 
				Ossification GO:0001503
				 The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance. 
			 | 
			1 | P20722 (/ISO) | 
| 
				Osteoblast differentiation GO:0001649
				 The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone. 
			 | 
			1 | Q04906 (/IEP) | 
| 
				Osteoblast differentiation GO:0001649
				 The process whereby a relatively unspecialized cell acquires the specialized features of an osteoblast, a mesodermal or neural crest cell that gives rise to bone. 
			 | 
			1 | P20722 (/IGI) | 
| 
				Eye development GO:0001654
				 The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight. 
			 | 
			1 | P20722 (/IGI) | 
| 
				Kidney development GO:0001822
				 The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. 
			 | 
			1 | P20722 (/IGI) | 
| 
				Positive regulation of endothelial cell proliferation GO:0001938
				 Any process that activates or increases the rate or extent of endothelial cell proliferation. 
			 | 
			1 | P20722 (/IDA) | 
| 
				Heart looping GO:0001947
				 The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation. 
			 | 
			1 | Q9PTF9 (/IMP) | 
| 
				Endochondral ossification GO:0001958
				 Replacement ossification wherein bone tissue replaces cartilage. 
			 | 
			1 | P20722 (/IMP) | 
| 
				Embryonic heart tube morphogenesis GO:0003143
				 The process in which the anatomical structures of the embryonic heart tube are generated and organized. The embryonic heart tube is an epithelial tube that will give rise to the mature heart. 
			 | 
			1 | Q9PTF9 (/IMP) | 
| 
				BMP signaling pathway involved in heart jogging GO:0003303
				 A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the process of heart jogging. 
			 | 
			1 | Q9PTF9 (/IMP) | 
| 
				Cellular iron ion homeostasis GO:0006879
				 Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell. 
			 | 
			1 | P20722 (/IMP) | 
| 
				Cellular iron ion homeostasis GO:0006879
				 Any process involved in the maintenance of an internal steady state of iron ions at the level of a cell. 
			 | 
			1 | P22004 (/ISS) | 
| 
				Inflammatory response GO:0006954
				 The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. 
			 | 
			1 | P20722 (/IEP) | 
| 
				Immune response GO:0006955
				 Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. 
			 | 
			1 | P22004 (/IMP) | 
| 
				Immune response GO:0006955
				 Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. 
			 | 
			1 | P20722 (/ISO) | 
| 
				Determination of left/right symmetry GO:0007368
				 The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry. 
			 | 
			1 | Q9PTF9 (/IMP) | 
| 
				Positive regulation of cell population proliferation GO:0008284
				 Any process that activates or increases the rate or extent of cell proliferation. 
			 | 
			1 | P22004 (/NAS) | 
| 
				Dorsal/ventral pattern formation GO:0009953
				 The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism. 
			 | 
			1 | Q9PTF9 (/IEP) | 
| 
				Dorsal/ventral pattern formation GO:0009953
				 The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism. 
			 | 
			1 | Q9PTF9 (/IGI) | 
| 
				Dorsal/ventral pattern formation GO:0009953
				 The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism. 
			 | 
			1 | Q9PTF9 (/IMP) | 
| 
				Response to iron ion GO:0010039
				 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus. 
			 | 
			1 | Q04906 (/IEP) | 
| 
				Positive regulation of gene expression GO:0010628
				 Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form. 
			 | 
			1 | P22004 (/IMP) | 
| 
				Response to activity GO:0014823
				 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an activity stimulus. 
			 | 
			1 | Q04906 (/IEP) | 
| 
				Locus ceruleus development GO:0021703
				 The process whose specific outcome is the progression of the locus ceruleus over time, from its formation to the mature structure. The locus ceruleus is a dense cluster of neurons within the dorsorostral pons. This nucleus is the major location of neurons that release norepinephrine throughout the brain, and is responsible for physiological responses to stress and panic. 
			 | 
			1 | Q9PTF9 (/IMP) | 
| 
				Cell differentiation GO:0030154
				 The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state. 
			 | 
			1 | P20722 (/IMP) | 
| 
				BMP signaling pathway GO:0030509
				 A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. 
			 | 
			1 | P22004 (/ISS) | 
| 
				Positive regulation of lipopolysaccharide-mediated signaling pathway GO:0031666
				 Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide. 
			 | 
			1 | P20722 (/IMP) | 
| 
				Positive regulation of lipopolysaccharide-mediated signaling pathway GO:0031666
				 Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide. 
			 | 
			1 | P22004 (/ISS) | 
| 
				Cellular response to extracellular stimulus GO:0031668
				 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an extracellular stimulus. 
			 | 
			1 | P20722 (/TAS) | 
| 
				Response to magnesium ion GO:0032026
				 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus. 
			 | 
			1 | Q04906 (/IEP) | 
| 
				Positive regulation of chondrocyte differentiation GO:0032332
				 Any process that activates or increases the frequency, rate or extent of chondrocyte differentiation. 
			 | 
			1 | Q04906 (/IDA) | 
| 
				Positive regulation of chondrocyte differentiation GO:0032332
				 Any process that activates or increases the frequency, rate or extent of chondrocyte differentiation. 
			 | 
			1 | P20722 (/ISO) | 
| 
				Positive regulation of aldosterone biosynthetic process GO:0032349
				 Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of aldosterone. 
			 | 
			1 | P22004 (/IDA) | 
| 
				Positive regulation of aldosterone biosynthetic process GO:0032349
				 Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of aldosterone. 
			 | 
			1 | P20722 (/ISO) | 
| 
				Response to retinoic acid GO:0032526
				 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a retinoic acid stimulus. 
			 | 
			1 | Q04906 (/IEP) | 
| 
				Post-anal tail morphogenesis GO:0036342
				 The process in which a post-anal tail is generated and organized. A post-anal tail is a muscular region of the body that extends posterior to the anus. The post-anal tail may aid locomotion and balance. 
			 | 
			1 | Q9PTF9 (/IMP) | 
| 
				Negative regulation of endodermal cell fate specification GO:0042664
				 Any process that restricts, stops or prevents a cell from specifying into an endoderm cell. 
			 | 
			1 | Q9PTF9 (/IGI) | 
| 
				Positive regulation of vascular permeability GO:0043117
				 Any process that increases the extent to which blood vessels can be pervaded by fluid. 
			 | 
			1 | P22004 (/IDA) | 
| 
				Regulation of cell differentiation GO:0045595
				 Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features. 
			 | 
			1 | Q04906 (/TAS) | 
| 
				Positive regulation of endothelial cell differentiation GO:0045603
				 Any process that activates or increases the frequency, rate or extent of endothelial cell differentiation. 
			 | 
			1 | P20722 (/IDA) | 
| 
				Positive regulation of osteoblast differentiation GO:0045669
				 Any process that activates or increases the frequency, rate or extent of osteoblast differentiation. 
			 | 
			1 | Q04906 (/IMP) | 
| 
				Positive regulation of transcription by RNA polymerase II GO:0045944
				 Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. 
			 | 
			1 | P20722 (/IMP) | 
| 
				Positive regulation of transcription by RNA polymerase II GO:0045944
				 Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. 
			 | 
			1 | P22004 (/ISS) | 
| 
				Positive regulation of transcription by RNA polymerase II GO:0045944
				 Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. 
			 | 
			1 | P22004 (/NAS) | 
| 
				Determination of ventral identity GO:0048264
				 The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized. 
			 | 
			1 | Q9PTF9 (/IDA) | 
| 
				Determination of ventral identity GO:0048264
				 The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized. 
			 | 
			1 | Q9PTF9 (/IGI) | 
| 
				Determination of ventral identity GO:0048264
				 The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized. 
			 | 
			1 | Q9PTF9 (/IMP) | 
| 
				Positive regulation of protein secretion GO:0050714
				 Any process that activates or increases the frequency, rate or extent of the controlled release of a protein from a cell. 
			 | 
			1 | P22004 (/NAS) | 
| 
				Positive regulation of peptidyl-tyrosine phosphorylation GO:0050731
				 Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. 
			 | 
			1 | P22004 (/IDA) | 
| 
				Response to glucocorticoid GO:0051384
				 Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glucocorticoid stimulus. Glucocorticoids are hormonal C21 corticosteroids synthesized from cholesterol with the ability to bind with the cortisol receptor and trigger similar effects. Glucocorticoids act primarily on carbohydrate and protein metabolism, and have anti-inflammatory effects. 
			 | 
			1 | Q04906 (/IEP) | 
| 
				Positive regulation of SMAD protein signal transduction GO:0060391
				 Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. 
			 | 
			1 | P20722 (/IMP) | 
| 
				Positive regulation of SMAD protein signal transduction GO:0060391
				 Any process that increases the rate, frequency or extent of SMAD protein signal transduction. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways. 
			 | 
			1 | P22004 (/ISS) | 
| 
				SMAD protein signal transduction GO:0060395
				 The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell. 
			 | 
			1 | P20722 (/IMP) | 
| 
				Multicellular organismal iron ion homeostasis GO:0060586
				 Any process involved in the maintenance of the distribution of iron stores within tissues and organs of a multicellular organism. 
			 | 
			1 | P20722 (/IMP) | 
| 
				Multicellular organismal iron ion homeostasis GO:0060586
				 Any process involved in the maintenance of the distribution of iron stores within tissues and organs of a multicellular organism. 
			 | 
			1 | P22004 (/ISS) | 
| 
				Protein-containing complex assembly GO:0065003
				 The aggregation, arrangement and bonding together of a set of macromolecules to form a protein-containing complex. 
			 | 
			1 | Q9PTF9 (/IMP) | 
| 
				Cellular response to mechanical stimulus GO:0071260
				 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. 
			 | 
			1 | Q04906 (/IEP) | 
| 
				Cellular response to iron ion GO:0071281
				 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus. 
			 | 
			1 | P20722 (/IMP) | 
| 
				Cellular response to iron ion GO:0071281
				 Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron ion stimulus. 
			 | 
			1 | P22004 (/ISS) | 
| 
				Negative regulation of adherens junction organization GO:1903392
				 Any process that stops, prevents or reduces the frequency, rate or extent of adherens junction organization. 
			 | 
			1 | P22004 (/IDA) | 
| 
				Negative regulation of cell-cell adhesion mediated by cadherin GO:2000048
				 Any process that stops, prevents, or reduces the frequency, rate or extent of cell-cell adhesion mediated by cadherin. 
			 | 
			1 | P22004 (/IDA) | 
| 
				Positive regulation of aldosterone secretion GO:2000860
				 Any process that activates or increases the frequency, rate or extent of aldosterone secretion. 
			 | 
			1 | Q04906 (/IDA) | 
| 
				Positive regulation of aldosterone secretion GO:2000860
				 Any process that activates or increases the frequency, rate or extent of aldosterone secretion. 
			 | 
			1 | P20722 (/ISO) | 
There are 16 GO terms relating to "cellular component"
			The search results have been sorted with the annotations that are found most frequently at the top of the
			list. The results can be filtered by typing text into the search box at the top of the table.
			
			
	| GO Term | Annotations | Evidence | 
|---|---|---|
| 
				Extracellular space GO:0005615
				 That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. 
			 | 
			19 | 			
			D4A7P9 (/IDA)
						
			G3V6W8 (/IDA)
						
			G3V6W8 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
						
			P18075 (/IDA)
							 (9 more) 			 | 
		
| 
				Extracellular region GO:0005576
				 The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. 
			 | 
			11 | 			
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
						
			P18075 (/TAS)
							 (1 more) 			 | 
		
| 
				Extracellular space GO:0005615
				 That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. 
			 | 
			10 | P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) | 
| 
				Vesicle GO:0031982
				 Any small, fluid-filled, spherical organelle enclosed by membrane. 
			 | 
			10 | P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) P22003 (/ISS) | 
| 
				Extracellular space GO:0005615
				 That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. 
			 | 
			5 | P20722 (/ISO) P23359 (/ISO) P23359 (/ISO) P49003 (/ISO) P49003 (/ISO) | 
| 
				Vesicle GO:0031982
				 Any small, fluid-filled, spherical organelle enclosed by membrane. 
			 | 
			5 | P20722 (/ISO) P23359 (/ISO) P23359 (/ISO) P49003 (/ISO) P49003 (/ISO) | 
| 
				Vesicle GO:0031982
				 Any small, fluid-filled, spherical organelle enclosed by membrane. 
			 | 
			4 | D4A7P9 (/IDA) G3V6W8 (/IDA) G3V6W8 (/IDA) Q04906 (/IDA) | 
| 
				Extracellular region GO:0005576
				 The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. 
			 | 
			2 | P27091 (/IDA) P27091 (/IDA) | 
| 
				Extracellular region GO:0005576
				 The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. 
			 | 
			2 | P27091 (/ISS) P27091 (/ISS) | 
| 
				Endomembrane system GO:0012505
				 A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles. 
			 | 
			2 | P27091 (/HDA) P27091 (/HDA) | 
| 
				Dense core granule GO:0031045
				 Electron-dense organelle with a granular internal matrix; contains proteins destined to be secreted. 
			 | 
			2 | P27091 (/IDA) P27091 (/IDA) | 
| 
				Collagen-containing extracellular matrix GO:0062023
				 An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells. 
			 | 
			2 | G3V6W8 (/IDA) G3V6W8 (/IDA) | 
| 
				Collagen-containing extracellular matrix GO:0062023
				 An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells. 
			 | 
			2 | P23359 (/ISO) P23359 (/ISO) | 
| 
				Extracellular space GO:0005615
				 That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. 
			 | 
			1 | P20722 (/HDA) | 
| 
				Cytoplasm GO:0005737
				 All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. 
			 | 
			1 | Q04906 (/IDA) | 
| 
				Cytoplasm GO:0005737
				 All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. 
			 | 
			1 | P20722 (/ISO) | 
